Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Fate Therapeutics (FATE) Interest Coverage Ratio (2016 - 2019)

Fate Therapeutics (FATE) has disclosed Interest Coverage Ratio for 7 consecutive years, with 53.55 as the latest value for Q4 2019.

  • For the quarter ending Q4 2019, Interest Coverage Ratio fell 37.55% year-over-year to 53.55, compared with a TTM value of 227.93 through Sep 2020, down 322.64%, and an annual FY2019 reading of 57.49, down 45.33% over the prior year.
  • Interest Coverage Ratio was 53.55 for Q4 2019 at Fate Therapeutics, up from 67.8 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 218.64 in Q4 2017 and bottomed at 67.8 in Q3 2019.
  • Average Interest Coverage Ratio over 5 years is 21.93, with a median of 37.48 recorded in 2017.
  • Peak annual rise in Interest Coverage Ratio hit 1039.82% in 2017, while the deepest fall reached 138.57% in 2017.
  • Year by year, Interest Coverage Ratio stood at 12.21 in 2015, then crashed by 90.59% to 23.26 in 2016, then surged by 1039.82% to 218.64 in 2017, then tumbled by 117.81% to 38.93 in 2018, then crashed by 37.55% to 53.55 in 2019.
  • Business Quant data shows Interest Coverage Ratio for FATE at 53.55 in Q4 2019, 67.8 in Q3 2019, and 58.89 in Q2 2019.